Capital Wealth Planning, LLC Astrazeneca PLC Transaction History
Capital Wealth Planning, LLC
- $10.5 Billion
- Q3 2024
A detailed history of Capital Wealth Planning, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Capital Wealth Planning, LLC holds 48,622 shares of AZN stock, worth $3.34 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
48,622
Previous 26,281
85.01%
Holding current value
$3.34 Million
Previous $2.05 Million
84.87%
% of portfolio
0.04%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,341Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.31 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.88 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.56 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.53 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.31 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $213B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...